Pfizer publishes application on varenicline prodrugs and vulnerable amine compounds.
The filing
Pfizer Inc. published an application on November 12, 2026, titled "Prodrugs of Varenicline and Compounds Containing Vulnerable Amines" US20260356854A1 (opens in a new tab). The document describes prodrugs of varenicline and compounds containing vulnerable amines.
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.